Viridian Therapeutics, Inc.\DE (VRDN) Change in Inventory (2013 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Change in Inventory of $2000.0 for Q4 2016, up 101.13% year-over-year from $994.38 in Q1 2016, and up 101.32% quarter-over-quarter from -$151000.0 in Q3 2016.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Change in Inventory (2013 - 2016) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Change in Inventory history runs 4 years deep, the most recent figure standing at $2000.0 for Q4 2016.
- In Q4 2016, Change in Inventory rose 101.13% year-over-year to $2000.0; the TTM figure through Dec 2016 stood at -$123000.0 (down 1637.5% YoY), while the FY2016 annual figure was -$123000.0, down 1637.5% from the prior year.
- Change in Inventory for Q4 2016 stood at $2000.0, up from -$151000.0 in the prior quarter.
- The five-year high for Change in Inventory was $206000.0 in Q2 2015, with the low at -$232000.0 in Q1 2014.
- The 4-year median for Change in Inventory is $20500.0 (2014), against an average of -$1968.6.
- Peak annual rise in Change in Inventory reached 202.94% in 2015, while the deepest fall reached 541.03% in 2015.
- Viridian Therapeutics, Inc.\DE's Change in Inventory stood at $147854.0 in 2013, then tumbled by 135.85% to -$53000.0 in 2014, then plunged by 233.96% to -$177000.0 in 2015, then soared by 101.13% to $2000.0 in 2016.
- Business Quant data shows VRDN's Change in Inventory at $2000.0 in Q4 2016, -$151000.0 in Q3 2016, and -$56000.0 in Q2 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.42 Bn | 2.42 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 2,000.00 |
| Sep 30, 2016 | -151,000.00 |
| Jun 30, 2016 | -56,000.00 |
| Mar 31, 2016 | 82,000.00 |
| Dec 31, 2015 | -177,000.00 |
| Sep 30, 2015 | -172,000.00 |
| Jun 30, 2015 | 206,000.00 |
| Mar 31, 2015 | 151,000.00 |
| Dec 31, 2014 | -53,000.00 |
| Sep 30, 2014 | 39,000.00 |
| Jun 30, 2014 | 68,000.00 |
| Mar 31, 2014 | -232,000.00 |
| Dec 31, 2013 | 147,854.00 |
| Sep 30, 2013 | 117,586.00 |